Kavault: Product Information

KAVAULT- avilamycin powder
Elanco US Inc.

Type A Medicated Article

Caution:

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

For Use in Type C Medicated Swine Feed Only

Do Not Use to Manufacture Type B Medicated Feed

Do not feed undiluted.

Active Drug Ingredient:

Avilamycin 90.7 g per lb (200 g per kg)

Inert ingredients:

Roughage products and mineral oil

Description:

Kavault Type A medicated article is a formulation of the antibiotic avilamycin. Avilamycin is in the orthosomycin class of antibiotics.

Indication:

For the reduction in incidence and overall severity of diarrhea in the presence of pathogenic Escherichia coli in groups of weaned pigs.

Feeding Directions:

Feed at 73 grams avilamycin per ton of Type C medicated feed (80 ppm) as the sole ration for 21 consecutive days. The veterinarian may direct feeding for up to a total of 42 consecutive days, based on the clinical assessment. Feed to pigs that are at risk of developing, but not yet showing clinical signs of, diarrhea in the presence of pathogenic Escherichia coli.

IMPORTANT: Must be thoroughly mixed in swine feed before use.

Mixing Directions:

Thoroughly mix Kavault Type A medicated article with a complete swine feed according to the table below to obtain the proper concentration in the Type C medicated feed. First, prepare an intermediate pre-blend by thoroughly mixing the required amount of Kavault Type A medicated article in a convenient quantity of feed ingredients, and then add the pre-blend to the remaining feed ingredients to make complete feed.

Starting concentration of Kavault Type A Medicated Article

Amount of Type A Medicated Article to add per ton

Resulting concentration in Type C Medicated Feed

grams per pound

pounds

grams per ton

90.7

0.8

73

Caution:

To assure responsible antimicrobial drug use in pigs, do not administer to pigs 14 weeks of age or older. Do not administer medicated feed containing avilamycin to pigs for more than a lifetime total of 42 days.

Avilamycin has not been demonstrated to be effective in pigs showing clinical signs of diarrhea prior to the start of medication.

The safety of avilamycin has not been established in swine intended for breeding purposes.

Veterinary Feed Directive (VFD) expiration date must not exceed 90 days from the date of issuance. VFDs for avilamycin shall not be refilled.

WARNINGS:

Residue Warning: No withdrawal period is required.

User Safety Warnings: Avilamycin may be irritating to the eyes and may cause allergic reactions in those hypersensitive to avilamycin. Avoid inhalation, oral exposure, and direct contact with skin or eyes. Operators mixing and handling Kavault should use protective clothing, impervious gloves, goggles, and an approved dust mask. Wash hands thoroughly with soap and water after handling. If accidental eye contact occurs, immediately rinse thoroughly with water and seek medical attention. If wearing contact lenses, rinse the eyes first, then remove contact lenses and continue to rinse the eyes thoroughly and seek medical attention. If accidental skin contact occurs, wash all exposed areas of skin thoroughly with soap and water, and seek medical attention if irritation develops. If accidental inhalation occurs, seek medical attention if breathing difficulty occurs. Not for human consumption. If accidental ingestion occurs, call a physician or poison control center. Do not induce vomiting. Keep out of reach of children. The Safety Data Sheet contains more detailed occupational safety information. To report adverse effects in users, to obtain more information, or to obtain a Safety Data Sheet, call 1-800-428-4441.

Adverse Drug Reactions: To report adverse effects, access medical information, or obtain additional product information, call 1-800-428-4441.

Storage Information:

Store at less than or equal to 25°C (77°F). Excursions to 40°C (104°F) are acceptable. Avoid excessive moisture.

Not to be used after the date printed on the bag.

Restricted Drug (California) — Use Only as Directed

Approved by FDA under NADA # 141-438

Product of the United Kingdom

Manufactured For:
Elanco US, Inc, Greenfield, IN 46140, USA
Kavault, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

Net Weight: 25 kg (55.12 lb)

TAKE TIME TO
OBSERVE LABEL
DIRECTIONS

BG230613X

Principal Display Panel – 25 kg Bag Label

Elanco™ AF0374

Kavault™

Avilamycin

Principal Display Panel -- 25 kg bag label
(click image for full-size original)
KAVAULT
avilamycin powder
Product Information
Product Type VFD TYPE A MEDICATED ARTICLE ANIMAL DRUG Item Code (Source) NDC:58198-0374
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
avilamycin (avilamycin) avilamycin 200 g in 1 kg
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:58198-0374-9 25 kg in 1 BAG None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA141438 05/08/2015
Labeler — Elanco US Inc. (966985624)
Establishment
Name Address ID/FEI Operations
TriRx Speke Limited 228138655 API MANUFACTURE, MANUFACTURE, PACK, LABEL

Revised: 07/2022 Elanco US Inc.

VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Our database mirrors the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VetLabel.com provides the full animal health subset of the FDA's repository. Veterinary information provided here is not intended as a substitute for direct consultation with a qualified veterinary professional.

Terms of Use | Copyright © 2024. All Rights Reserved.